These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 14555538

  • 41. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J, Nevozhay D, Filip B, Milczarek M, Kutner A.
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [Abstract] [Full Text] [Related]

  • 42. [Antitumor effect of recombinant Xenopus laevis vascular endothelial growth factor (VEGF) as a vaccine combined with adriamycin on EL4 lymphoma in mice].
    Niu T, Liu T, Jia YQ, Liu JY, Wu Y, Hu B, Tian L, Yang L, Kan B, Wei YQ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):661-4, 675. PubMed ID: 16235531
    [Abstract] [Full Text] [Related]

  • 43. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, Bandyopadhyay A, Knight V, Gilbert BE, Sanders BG, Kline K.
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
    [Abstract] [Full Text] [Related]

  • 44. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA, Ara G, Buxton D, Leonard J, Schaub RG.
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y.
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yanase K, Yoshiji H, Ikenaka Y, Noguchi R, Kitade M, Kaji K, Yoshii J, Namisaki T, Yamazaki M, Asada K, Tsujimoto T, Akahane T, Uemura M, Fukui H.
    Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ.
    Clin Cancer Res; 2006 Nov 01; 12(21):6573-84. PubMed ID: 17085673
    [Abstract] [Full Text] [Related]

  • 53. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
    Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS.
    J Clin Oncol; 2006 Aug 01; 24(22):3555-61. PubMed ID: 16877721
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Autocrine expression of both endostatin and green fluorescent protein provides a synergistic antitumor effect in a murine neuroblastoma model.
    Davidoff AM, Leary MA, Ng CY, Spurbeck WW, Frare P, Vanhove M, Nienhuis AW, Vanin EF.
    Cancer Gene Ther; 2001 Jul 01; 8(7):537-45. PubMed ID: 11498776
    [Abstract] [Full Text] [Related]

  • 59. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W, Mlynarczuk I, Balkowiec-Iskra EZ, Czajka A, Switaj T, Stoklosa T, Giermasz A, Jakóbisiak M.
    Clin Cancer Res; 2000 May 01; 6(5):2044-52. PubMed ID: 10815931
    [Abstract] [Full Text] [Related]

  • 60. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy.
    Ulmer W.
    Strahlenther Onkol; 1991 Sep 01; 167(9):553-60. PubMed ID: 1925940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.